Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic renal disease: safety issues-Reference-Cited by-同舟云学术

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic renal disease: safety issues

Published:2004-03 Issue:2 Volume:24 Page:168-175
ISSN:0270-9295
Container-title:Seminars in Nephrology
language:en
Short-container-title:Seminars in Nephrology

Author:

Mangrum Amy J,Bakris George L

Publisher

Elsevier BV

Subject

Nephrology

Reference55 articles.

1. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure;Chobanian;JAMA,2003

2. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease;Wright;JAMA,2002

3. Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The “Gruppo Italiano di Studi Epidemiologici in Nefrologia” (GISEN);Ruggenenti;Kidney Int Suppl,1997

4. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy;Lewis;N Engl J Med,1993

5. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes;Lewis;N Engl J Med,2001

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapy of hypertension in patients with pre-dialysis chronic kidney disease;Expert Opinion on Pharmacotherapy;2020-02-19

2. Assessment of the effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in peritoneal dialysis patients: a systematic review and meta-analysis on clinical trials;Renal Replacement Therapy;2019-09-14

3. Protection of the kidney with sodium–glucose cotransporter 2 inhibitors: potential mechanisms raised by the large-scaled randomized control trials;Clinical and Experimental Nephrology;2018-11-26

4. Amelioration of Diabetes-Induced Diabetic Nephropathy byAloe vera: Implication of Oxidative Stress and Hyperlipidemia;Journal of Dietary Supplements;2018-04-05

5. Activation and Inhibition of Sodium-Hydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure;Circulation;2017-10-17